NO308901B1 - Farmasøytisk aktiv forbindelse i form av (R)-(Z)-1- azabicyklo[2.2.1]heptan-3-on,O-[3-(3-metoksyfenyl)-2- propynyl]oksim-maleat, farmasøytisk preparat omfattende denne, samt anvendelse av forbindelsen - Google Patents

Farmasøytisk aktiv forbindelse i form av (R)-(Z)-1- azabicyklo[2.2.1]heptan-3-on,O-[3-(3-metoksyfenyl)-2- propynyl]oksim-maleat, farmasøytisk preparat omfattende denne, samt anvendelse av forbindelsen

Info

Publication number
NO308901B1
NO308901B1 NO975704A NO975704A NO308901B1 NO 308901 B1 NO308901 B1 NO 308901B1 NO 975704 A NO975704 A NO 975704A NO 975704 A NO975704 A NO 975704A NO 308901 B1 NO308901 B1 NO 308901B1
Authority
NO
Norway
Prior art keywords
compound
heptan
azabicyclo
propynyl
methoxyphenyl
Prior art date
Application number
NO975704A
Other languages
English (en)
Norwegian (no)
Other versions
NO975704D0 (no
NO975704L (no
Inventor
Howard Yoshihisa Ando
Stephen Douglas Barrett
Juan Carlos Jaen
Steven Edward Rose
Haile Tecle
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO975704D0 publication Critical patent/NO975704D0/no
Publication of NO975704L publication Critical patent/NO975704L/no
Publication of NO308901B1 publication Critical patent/NO308901B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
NO975704A 1995-06-07 1997-12-05 Farmasøytisk aktiv forbindelse i form av (R)-(Z)-1- azabicyklo[2.2.1]heptan-3-on,O-[3-(3-metoksyfenyl)-2- propynyl]oksim-maleat, farmasøytisk preparat omfattende denne, samt anvendelse av forbindelsen NO308901B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/474,622 US5534522A (en) 1995-06-07 1995-06-07 (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent
PCT/US1996/006814 WO1996040687A1 (en) 1995-06-07 1996-05-13 (r)-(z)-1-azabicyclo[2.2.1]heptan-3-one,o-[3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent

Publications (3)

Publication Number Publication Date
NO975704D0 NO975704D0 (no) 1997-12-05
NO975704L NO975704L (no) 1998-01-30
NO308901B1 true NO308901B1 (no) 2000-11-13

Family

ID=23884337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975704A NO308901B1 (no) 1995-06-07 1997-12-05 Farmasøytisk aktiv forbindelse i form av (R)-(Z)-1- azabicyklo[2.2.1]heptan-3-on,O-[3-(3-metoksyfenyl)-2- propynyl]oksim-maleat, farmasøytisk preparat omfattende denne, samt anvendelse av forbindelsen

Country Status (25)

Country Link
US (1) US5534522A (xx)
EP (1) EP0839148B1 (xx)
JP (1) JPH11506723A (xx)
KR (1) KR100383031B1 (xx)
CN (1) CN1063181C (xx)
AT (1) ATE187967T1 (xx)
BG (1) BG63571B1 (xx)
CA (1) CA2219753A1 (xx)
CZ (1) CZ286528B6 (xx)
DE (1) DE69605800T2 (xx)
DK (1) DK0839148T3 (xx)
EA (1) EA000381B1 (xx)
EE (1) EE03971B1 (xx)
ES (1) ES2142586T3 (xx)
GE (1) GEP19991874B (xx)
GR (1) GR3032772T3 (xx)
HK (1) HK1018055A1 (xx)
HU (1) HUP9802499A3 (xx)
NO (1) NO308901B1 (xx)
NZ (1) NZ307946A (xx)
PL (1) PL323796A1 (xx)
SK (1) SK282824B6 (xx)
UA (1) UA46032C2 (xx)
WO (1) WO1996040687A1 (xx)
ZA (1) ZA964764B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
DK1670785T3 (da) * 2003-10-02 2010-10-18 Pharmacia & Upjohn Co Llc Salte og polymorphe former af en pyrrolsubstitueret indolinonforbindelse
US7741358B2 (en) * 2005-04-14 2010-06-22 N.V. Organon Crystal form of asenapine maleate
US20090298814A1 (en) * 2005-06-07 2009-12-03 Ramot At Tel Aviv Univeristy Ltd Novel salts of conjugated psychotropic drugs and processes of preparing same
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2051735B1 (en) 2006-07-17 2012-08-29 Ramot, at Tel Aviv University Ltd. Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use treating pain and other cns disorders
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8207369B2 (en) 2008-02-11 2012-06-26 Ramot At Tel-Aviv University Ltd. Conjugates for treating neurodegenerative diseases and disorders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
MX2012006566A (es) 2009-12-09 2012-11-29 Univ Ramot Metodo para mejorar las funciones cognoscitivas.
US8377929B2 (en) 2010-02-24 2013-02-19 Ramot At Tel-Aviv University Ltd. Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same
US8916610B2 (en) 2010-09-22 2014-12-23 Ramot At Tel-Aviv University Ltd. Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same
JP5997931B2 (ja) * 2011-05-25 2016-09-28 石原産業株式会社 農園芸用殺菌剤組成物及び植物病害の防除方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346911A (en) * 1990-03-06 1994-09-13 Warner-Lambert Company Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
US5306718A (en) * 1990-03-06 1994-04-26 Warner-Lambert Company Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment

Also Published As

Publication number Publication date
SK282824B6 (sk) 2002-12-03
EA000381B1 (ru) 1999-06-24
GR3032772T3 (en) 2000-06-30
ZA964764B (en) 1997-01-08
DE69605800D1 (de) 2000-01-27
NO975704D0 (no) 1997-12-05
US5534522A (en) 1996-07-09
KR19990022572A (ko) 1999-03-25
HK1018055A1 (en) 1999-12-10
EE03971B1 (et) 2003-02-17
ES2142586T3 (es) 2000-04-16
EA199800007A1 (ru) 1998-06-25
HUP9802499A2 (hu) 1999-04-28
NZ307946A (en) 2001-03-30
CA2219753A1 (en) 1996-12-19
KR100383031B1 (ko) 2003-10-17
UA46032C2 (uk) 2002-05-15
BG63571B1 (bg) 2002-05-31
ATE187967T1 (de) 2000-01-15
DK0839148T3 (da) 2000-05-22
SK164497A3 (en) 1998-06-03
NO975704L (no) 1998-01-30
EE9700316A (et) 1998-06-15
GEP19991874B (en) 1999-12-06
AU697954B2 (en) 1998-10-22
CZ381797A3 (cs) 1998-05-13
EP0839148B1 (en) 1999-12-22
CN1186493A (zh) 1998-07-01
HUP9802499A3 (en) 1999-06-28
CZ286528B6 (cs) 2000-05-17
EP0839148A1 (en) 1998-05-06
WO1996040687A1 (en) 1996-12-19
CN1063181C (zh) 2001-03-14
PL323796A1 (en) 1998-04-27
AU5744996A (en) 1996-12-30
JPH11506723A (ja) 1999-06-15
BG102078A (en) 1998-11-30
DE69605800T2 (de) 2000-11-16

Similar Documents

Publication Publication Date Title
NO308901B1 (no) Farmasøytisk aktiv forbindelse i form av (R)-(Z)-1- azabicyklo[2.2.1]heptan-3-on,O-[3-(3-metoksyfenyl)-2- propynyl]oksim-maleat, farmasøytisk preparat omfattende denne, samt anvendelse av forbindelsen
LU92132I2 (fr) Sel d'aclidinium avec anion d'un acide mono ou polyvalent pharmaceutiquement acceptable particulièrement le bromure d'aclidinium
CA2149242A1 (en) Quinuclidine Derivative for Treatment of Inflammatory and Gastrointestinal Disorders
EP0852117A4 (en) IMPROVEMENT OF LIPID METABOLISM
CA2246839A1 (en) Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy
CA2176298A1 (en) A single high dose fluoroquinolone treatment
CA2155323A1 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
EP0214557A3 (en) Use of serotonin antagonists, particularly cyproheptadine, in the treatment of cancer, alzheimer's disease, aids and multiple sclerosis
CA2300289A1 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
HU900255D0 (en) Process for preparation of 3-phenyl-5,6-dilhydrobenz (c)-acridine-carboxylic-acids and carboxylic-acid derivatives and for manufacturing of pharmaceutical composition containing these compounds as active ingredient
IT8022843A0 (it) Sali di endo-8-metil-8-sin-alchil-8-azoniabiciclo aperta par. quadrata 3.2.1.chiusa par.quadrata-ottan-3-alchilcarbossilati , processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo.
MX9708337A (es) Maleato (r)-(z)-1-azabiciclo [2.2.1]heptan-3-one,0-[3-(3-metoxifenil)-2-propinil]-oxime como un agente farmaceutico.
CA2189762A1 (en) Use of no scavengers, inhibitors or antagonists in the treatment of migraine
NO175565C (no) Fremgangsmåte for fremstilling av et parenteralt anvendbart, farmasöytisk preparat inneholdende et bis-indolalkaloid
MY115734A (en) Resolution of 1-azabicyclo (2.2.2.) octon -3-amine, 2-(diphenylmethyl)-n- [[2-methoxy-5-(1-mehtylethyl) phenyl]methyl]
IE890232L (en) Condensed diazepinones
CA2222552A1 (en) N-oxides as antibacterial agents
BR9808428A (pt) Composição farmacêutica, processo para tratar distúrbios alérgicos em um mamìfero e forma de dosagem unitária sólida
AU3978095A (en) Heterocyclic compounds and their preparation and use
EP0318166A3 (en) Isoxazolo[4,5-c]azepine derivatives, process for their preparation and pharmaceutical compositions containing them
EP0396169A3 (en) Pharmaceutical composition for topical ophthalmic use having improved local tolerability
Takayanagi et al. A new parasympathomimetic agent: 1-methyl-5-chloroindoline methylbromide
MX9706044A (es) Composicion farmaceutica para la aplicacion parenteral, que contiene un acido indol-carboxilico.
CA2053346A1 (en) Microcapsule compositions for torical treatment
BG104162A (en) Pharmaceutical composition active in the reduction of the mcp-1 protein production

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees